Position in LLY
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$17,210,622
+$4,412,023 QoQ
Shares Held
14,349
+3.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.45%
of 13F equity value
Holder Rank
#967
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fulton Bank, N.A. holds $64,915,903 across 12 Drug Manufacturers - General names. LLY ranks #1 (26.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
14,349 | $17,210,622 | |
| 2 | ABBV |
AbbVie Inc.
|
52,406 | $13,187,445 | |
| 3 | MRK |
Merck & Co., Inc.
|
80,029 | $10,283,726 | |
| 4 | JNJ |
Johnson & Johnson
|
32,005 | $8,128,309 | |
| 5 | AMGN |
Amgen Inc
|
14,713 | $5,327,871 | |
| 6 | PFE |
Pfizer Inc
|
128,183 | $3,086,646 | |
| 7 | SNY |
Sanofi
|
68,196 | $2,909,240 | |
| 8 | AZN |
Astrazeneca PLC
|
8,294 | $1,572,707 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,210,622 | 14,349 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $12,798,599 | 13,915 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $14,666,159 | 13,647 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $9,708,412 | 12,724 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $10,276,543 | 13,183 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $11,560,261 | 13,997 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $11,393,176 | 14,758 | Shares | Sole | 2025-01-08 | |
| 2024-09-30 | $11,938,926 | 13,476 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $12,115,794 | 13,382 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $9,057,010 | 11,642 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $6,598,071 | 11,319 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $6,334,911 | 11,794 | Shares | Sole | 2023-10-04 | |
| 2023-06-30 | $5,154,089 | 10,990 | Shares | Sole | 2023-07-06 | |
| 2023-03-31 | $3,922,543 | 11,422 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $4,098,504 | 11,203 | Shares | Sole | 2023-01-05 | |
| 2022-09-30 | $3,668,081 | 11,344 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $3,763,661 | 11,608 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $3,455,626 | 12,067 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $2,886,774 | 10,451 | Shares | Sole | 2022-01-05 | |
| 2021-09-30 | $2,302,412 | 9,965 | Shares | Sole | 2021-10-05 | |
| 2021-06-30 | $1,709,235 | 7,447 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $1,468,217 | 7,859 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $3,885,176 | 23,011 | Shares | Sole | 2021-01-07 | |
| 2020-09-30 | $3,368,046 | 22,754 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $3,547,272 | 21,606 | Shares | Sole | 2020-07-06 | |
| 2020-03-31 | $881,426 | 6,354 | Shares | Sole | 2020-04-03 | |
| No filing history on record for this holder in this stock. | ||||||